Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You would have to read 2020 year end to get a sense for what this last quarter will look like. EBITDA, outstanding shares, revenue, all point to an undervalued, under the radar, share price.
So one more year until breakeven. If you're a long term investor, now (or perhaps waiting until the height of the summer doldrums) is probably a good time to load up on cheapies, unless of course there is some huge catalyst like legalization, but I don't see that happening until next session of Congress. If it happens before Summer recess I'd be surprised.
Ouch! looks like this POS is going GREY SHEETS! lolzzzz
Yes, in accounting terms when you put brackets around it means negative. Sorry, I would use red font too, but don't know how on IHUB. Yes, NEGATIVE earnings.
As I said before, EBITDA is just smoke and mirrors.
They has good momentum. I am ready.
So how do you think they will do? Best guess.
TILT Holdings Inc.'s (CSE:TILT) About To Shift From Loss To Profit
By Simply Wall St
Published May 12, 2021
CNSX:TILT
We feel now is a pretty good time to analyse TILT Holdings Inc.'s (CSE:TILT) business as it appears the company may be on the cusp of a considerable accomplishment. TILT Holdings Inc., a vertically-integrated technology and infrastructure company, provides various products and services across the cannabis industry in the United States, Canada, and Europe. The CA$188m market-cap company announced a latest loss of US$52m on 31 December 2020 for its most recent financial year result. As path to profitability is the topic on TILT Holdings' investors mind, we've decided to gauge market sentiment. Below we will provide a high-level summary of the industry analysts’ expectations for the company.
See our latest analysis for TILT Holdings
Consensus from 2 of the Canadian Pharmaceuticals analysts is that TILT Holdings is on the verge of breakeven. They anticipate the company to incur a final loss in 2020, before generating positive profits of US$1.6m in 2021. So, the company is predicted to breakeven approximately a year from now or less! How fast will the company have to grow to reach the consensus forecasts that anticipate breakeven by 2021? Working backwards from analyst estimates, it turns out that they expect the company to grow 147% year-on-year, on average, which is rather optimistic! If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.
CNSX:TILT Earnings Per Share Growth May 12th 2021
Given this is a high-level overview, we won’t go into details of TILT Holdings' upcoming projects, though, bear in mind that by and large pharmaceuticals, depending on the stage of product development, have irregular periods of cash flow. So, a high growth rate is not out of the ordinary, particularly when a company is in a period of investment.
One thing we’d like to point out is that The company has managed its capital judiciously, with debt making up 26% of equity. This means that it has predominantly funded its operations from equity capital, and its low debt obligation reduces the risk around investing in the loss-making company.
TILT Holdings to Report First Quarter Results on Tuesday, May 25, 2021
May 11, 2021 06:00 ET
Source: TILT Holdings Inc.
PHOENIX, May 11, 2021 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT or the “Company”) (CSE: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, will report its financial results for the first quarter ended March 31, 2021 after market close on Tuesday, May 25.
TILT’s management team will host a webcast at 5:00 p.m. ET to review the Company’s operational and financial highlights, followed by a question-and-answer session.
Event: TILT First Quarter 2021 Results Conference Call
Date: Tuesday, May 25, 2021
Time: 5:00 p.m. ET
Live Call: 1-877-705-6003
Webcast: public.viavid.com/index.php?id=144960
Interested individuals can register for the webcast via the Company’s Investor Relations website. A replay of the call will also be available for approximately 30 days. Please remember to join the webcast approximately 10 minutes prior to the start time to install any necessary software that may be required to join the call.
About TILT
TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 36 states in the U.S., as well as Canada, Israel, Mexico, South America and the European Union. TILT’s core businesses include Jupiter Research LLC, a wholly-owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations, Commonwealth Alternative Care, Inc. in Massachusetts, Standard Farms LLC in Pennsylvania and Standard Farms Ohio, LLC in Ohio. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com.
The CSE has neither approved nor disapproved the contents of this news release.
Media Contact:
Ellen Mellody
Ellen@mattio.com
570-209-2947
Investor Relations Contact:
Taylor Allison
investors@tiltholdings.com
Agree, looking forward to it.
For one thing, TILT is flying under the radar. Gets very little attention. They are not in the discussion, yet. No pump, no mojo. I believe they will find a story or two and will gain a little traction, soon.
I bet we'll continue to see some good improvements and on par w/ previous qtr.
Same view as last qtr.
I suspect the move higher comes q3/q4, or 1Q2022.
Great qtrs in USA canna space haven't been rewarded this earnings season.
Even if Tilt delivers solid results, I'm doubtful on pps moving much.
Look at all USA Leaders...why would it be any different for tilt?
GLTA
GW
I see -$0.29/share EPS. You meant -$.33 and not +$.33 when you wrote that, right? I read it as +.33 and that caught my attention.
TLLTF
Looking forward to it.
Outstanding Shares
324,753,294
05/13/2021
Estimated 2021 annual income $205,000,000 to $210,000,000
Adjusted EBITDA $30,000,000 to $32,000,000
April 15, 2021 Full 2020 year earnings report
Full-year 2020 Adjusted EBITDA of $16.9 million compared to Adjusted EBITDA loss of $0.8 million in 2019
Full-year 2020 cash from operating activities improved $34.2 million compared to 2019 Full-year 2020 cannabis revenue increased 41% compared to 2019
Full-year cash expenses decreased 30% compared to 2019
I continue to keep my eye on this one, but I still can't get over the fact the share price is $.46/sh and the most recent qtrly EPS is ($.33)/sh.
2 more trading days until earnings release.
I hope so, but I'm still skeptical as we move into the summer.
I'm convinced this summer w/ be like the past several. Only thing potentially bucking trend is legalization.
We're already seeing sweet Q's being completely ignored on USA canna leaders.
Personally, I don't think the Dems move on anything until late 2021 or early 2022. Before recess is doubtful, imo ...but i'd love to be surprised
Doesn't change my holdings, but I'm willing to wait for deep summer before adding to my large stack here.
GLTA
GW
Last chance under 0.50
Picked up last 2k @ 0.49
AVERAGE VOL (30D)
356,601
VOLUME with 1:15 left in trading day
351,000
TITLT Holdings
Recently bought at $0.42 and just now at $0.48
I refuse to pay more than $0.495
May 14th
TILT Holdings
$0.4591 (now $0.48)
I added to my position at $0.42
Looking to add another 1,000 shares at $0.42 to bring my total to 55,000 shares
Reporting next financial quarter on May 25th
What this means
A move of one cent $0.44 = $550
A move of 5 cents $0.48 = $2,750
A move of 25 cents $0.68 $13,750
A move of one dollar $1.43 $55,000
Total shares outstanding 330,000,000
Estimated 2021 annual income $205,000,000 to $210,000,000
Adjusted EBITDA $30,000,000 to $32,000,000
April 15, 2021 Full 2020 year earnings report
Full-year 2020 Adjusted EBITDA of $16.9 million compared to Adjusted EBITDA loss of $0.8 million in 2019 Full-year 2020 cash from operating activities improved $34.2 million compared to 2019 Full-year 2020 cannabis revenue increased 41% compared to 2019 Full-year cash expenses decreased 30% compared to 2019
Either this is undiscovered or I am flawed.
Good video interview.
Like seeing Gary take the lead role here.
TLLTF
#TLLTF: ALL THE WAY TO $3.00.... GO oliver 0.45
https://seekingalpha.com/news/3682007-tilt-holdings-beats-on-revenue?utm_source=advfn.com&utm_medium=referral
Revenue of $42.3M (+35.4% Y/Y) beats by $0.43M.
#TLLTF: Long term, I'm excited for future potential.. GO greenwillow
LEADING THE CANNABIS NATION TO GREATNESS...
#TLLTF: MM's HAVE A DUE DATE...05/25/2021...!
https://www.otcmarkets.com/stock/TLLTF/news/TILT-Holdings-to-Report-First-Quarter-Results-on-Tuesday-May-25-2021?id=302233
#TLLTF:...0.45... Go JohnMC
Thanks for the Heads up John...!
https://www.otcmarkets.com/stock/TLLTF/profile
FLOAT.....278 M
MC........147 M
I WANT IN...!
https://www.tiltholdings.com/
https://twitter.com/tilt_holdings
TILT Holdings President Gary Santo to Succeed Mark Scatterday as CEO; Scatterday to Continue Serving as Chairman of the Board
May 14, 2021 06:00 ET | Source: TILT Holdings Inc.
PHOENIX, May 14, 2021 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT" or the “Company”) (CSE: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced that current President Gary Santo will be appointed as the Company’s new Chief Executive Officer ("CEO"), effective June 1, 2021. Current CEO Mark Scatterday will continue to serve as Chairman of the Board and will work closely with Mr. Santo and the senior management team. He will also serve as a special advisor to TILT’s research and development team as they continue to create new technology and product innovations.
“This is an exciting time for TILT and the cannabis industry as consumer adoption and demand continues to accelerate,” said Mark Scatterday, current Chairman & CEO of TILT. “Since joining TILT last year, Gary has been an integral part of our leadership team as he brought a wealth of experience in both cannabis and other highly regulated sectors. His development and implementation of our long-term strategy has been key to our return to growth and profitability. I look forward to continuing to work closely with him, our board and the research and development team.”
Current TILT President Gary Santo added, “It is an honor to become the CEO of such a forward-thinking, innovative company and to work alongside such a talented and passionate team. TILT has been given a rare opportunity in the cannabis sector to have a second act, and the Company has proven its commitment to value creation by divesting unprofitable business segments and repositioning itself to better serve consumers, MSOs, licensed producers and cannabis brands around the globe. These efforts have enabled our robust growth outlook for 2021, which has us nearly doubling adjusted EBITDA to $30-$32 million. As we continue to execute on our growth initiatives, I am excited to lead the team into what promises to be an exciting few years ahead.”
Santo continued, “I’d like to express my deepest gratitude to Mark for this opportunity. Together with our prior President and Chief Operating Officer Tim Conder, Mark successfully stabilized TILT’s foundation during a pivotal transition period for the Company. I look forward to continuing to work closely with him as we lead TILT into its next chapter of growth.”
Mr. Santo was appointed President of TILT in October 2020. Since that time, he has solidified TILT’s B2B strategy, executed on strategic distribution and brand partnerships, and made key hires across compliance, marketing and human resources. Mr. Santo brings more than 25 years of experience leading lean, high-performance teams in consumer credit, financial services, gaming and technology, higher education and specialty-pharma. He has held a variety of senior roles at The First Marblehead Corporation, Fitch Ratings, International Game Technology, Lantheus Medical Imaging and most recently, Columbia Care Inc., a leading multi-state operator in the cannabis industry. Santo holds an Investor Relations Charter® certification from the National Investor Relations Institute, as well as a degree in Political Science from Boston University.
About TILT
TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 36 states in the U.S., as well as Canada, Israel, Mexico, South America and the European Union. TILT’s core businesses include Jupiter Research LLC, a wholly-owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations, Commonwealth Alternative Care, Inc. in Massachusetts, Standard Farms LLC in Pennsylvania and Standard Farms Ohio, LLC in Ohio. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com.
avg vol 352,042
I like the spot.
GL
All in all I bought 7,000 shares today. 3,000 at $0.42
05/13/2021 Buy 1,000 Shares of TLLTF Limit at $0.42 (Day)
Open
Cancel Replace
--
05/13/2021 Buy 2,000 Shares of TLLTF Limit at $0.42 (Day) Filled at $0.42
$840.00
05/13/2021 Buy 2,000 Shares of TLLTF Limit at $0.41 (Day)
Open
Cancel Replace
--
05/13/2021 Buy 2,000 Shares of TLLTF Limit at $0.40 (Day)
Open
Cancel Replace
--
I thought $0.42 would worth a flyer with earnings due on the 25th.
Full Year 2021 Outlook:
2021 strategic initiatives fully funded; outlook not expected to require significant CAPEX or M&A.
Revenue range of $205 million to $210 million
Adjusted EBITDA range of $30 million to $32 million
Yeah, might be a great spot...Especially if looking to sell on a quick bounce.
It'll move around here & there, but we're headed into summer months.
Will there be a summer catalyst this year? Possibly, but what if there isn't?
What if Schumer continues to drag feet?
Rumors of getting something done before recess are out there, but do you trust that'll happen? 50/50, imo
I'm not going to fight the multi year summer trend of depressed pps, volume & liquidity within the canna space.
Already have several names throughout space, so if trend is bucked, great! If not, I'm adding late summer @ seriously depressed summer pps across the space. Happens every year.
Look at USA leadership w/ great earnings this week. Strengthening fundamentals are out the window in the space. Doesn't matter right now.
Anyways, that's my short term take.
Long term, I'm excited for future potential.
GLTA
GW
TILT Holdings (TLLTF)
Picked up shares at $0.42
I have open orders at $0.42 $0.41 and $0.40
I own a nice position here.
My only hesitation, right now, is the summer doldrums & potential for deeply depressed pps into late summer months.
I'm waiting to add late Aug.
GL
This is big for me and my portfolio
TILT Holdings to Report First Quarter Results on Tuesday, May 25, 2021
BY GlobeNewswire
6:00 AM ET 05/11/2021
PHOENIX, May 11, 2021 (GLOBE NEWSWIRE) -- TILT Holdings Inc. ( TLLTF ) (“TILT or the “Company”) (CSE: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, will report its financial results for the first quarter ended March 31, 2021 after market close on Tuesday, May 25.
TILT’s management team will host a webcast at 5:00 p.m. ET to review the Company’s operational and financial highlights, followed by a question-and-answer session.
Event: TILT First Quarter 2021 Results Conference Call
Date: Tuesday, May 25, 2021
Time: 5:00 p.m. ET
Live Call: 1-877-705-6003
Webcast: public.viavid.com/index.php?id=144960
LAST QUARTER
Financial Highlights from Continuing Operations for the Quarter Ended December 31, 2020
• Revenue of $42.3 million, an 8.1% increase from the third quarter of 2020 and an increase of 35.4% from the prior year period.
• Gross margin before fair value adjustments of 26.7%, down 460 basis points (“bps”) from the third quarter of 2020 and up 200 bps from the prior year period.
• Operating expenses less non-cash adjustments for stock compensation, depreciation/ amortization and one-time charges was $8.3 million, flat compared to the third quarter and a 17.7% decline from the prior year period.
• Positive Adjusted EBITDA for the fourth consecutive quarter at $4.5 million.
• Cash and cash equivalents of $7.4 million, a $3.1 million increase from the previous quarter, due to robust cashflow from operations.
• Working Capital of $57.4 million, an $8.5 million increase from the previous quarter.
TILT Holdings Full Year 2021 Outlook:
2021 strategic initiatives fully funded; outlook not expected to require significant CAPEX or M&A.
Revenue range of $205 million to $210 million
Adjusted EBITDA range of $30 million to $32 million
I like TILT over time.
Followers
|
49
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
931
|
Created
|
12/27/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |